Citation Impact
Citing Papers
Complement drives Th17 cell differentiation and triggers autoimmune arthritis
2010 StandoutNobel
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
2004 StandoutScience
C3 Promotes Expansion of CD8+ and CD4+ T Cells in a Listeria monocytogenes Infection
2009
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples
2011
Guidelines for the welfare and use of animals in cancer research
2010 Standout
LinkedOmics: analyzing multi-omics data within and across 32 cancer types
2017 Standout
AIF meets the CHCHD4/Mia40-dependent mitochondrial import pathway
2020
Hyaluronic Acid Hydrogels for Biomedical Applications
2011 Standout
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
2015 Standout
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
2009 Standout
Complement and its role in innate and adaptive immune responses
2009 Standout
Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance
2006
B1b Lymphocytes Confer T Cell-Independent Long-Lasting Immunity
2004 StandoutNobel
The WNT/Beta-catenin pathway in melanoma
2006
A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family
2002
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Biomarkers in melanoma: predisposition, screening and diagnosis
2003
Apoptosis: controlled demolition at the cellular level
2007 Standout
Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms
2004
Zinc-finger proteins in health and disease
2017
Tailoring to RB: tumour suppressor status and therapeutic response
2008
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Dendritic cell-based vaccine: a promising approach for cancer immunotherapy
1999
Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial
2008 Standout
Alarmins: chemotactic activators of immune responses
2005
A Systematic Review and Meta-analysis of Adjuvant and Neoadjuvant Chemotherapy for Upper Tract Urothelial Carcinoma
2014
Cisplatin Nephrotoxicity: A Review
2007 Standout
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
2006 Standout
Modulation of Cell Cycle Components by Epigenetic and Genetic Events
2005
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvant
1998 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Neutrophils in the activation and regulation of innate and adaptive immunity
2011 Standout
Phosphorylation by Casein Kinase I Promotes the Turnover of the Mdm2 Oncoprotein via the SCFβ-TRCP Ubiquitin Ligase
2010 StandoutNobel
RB and cell cycle progression
2006 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Blinded by the Light: The Growing Complexity of p53
2009 Standout
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer
2000
Human Plasmacytoid Dendritic Cells Express Receptors for Anaphylatoxins C3a and C5a and Are Chemoattracted to C3a and C5a
2006
Cellular Responses to Cisplatin‐Induced DNA Damage
2010
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Intravital microscopy of tumor angiogenesis and regression in the dorsal skin fold chamber: mechanistic insights and preclinical testing of therapeutic strategies
2009
Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress.
2004
Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: Insights from the study of fish complement
2005
Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation
2008
3D bioprinting of tissues and organs
2014 Standout
Serotypes of <EMPH TYPE="ITAL">Chlamydia trachomatis</EMPH> and Risk for Development of Cervical Squamous Cell Carcinoma
2001
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Translation of new cancer treatments from pet dogs to humans
2008 Standout
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
The MDM2 gene amplification database
1998
A multidisciplinary approach to honest broker services for tissue banks and clinical data
2008
EMT: 2016
2016 Standout
Reduced Pain Hypersensitivity and Inflammation in Mice Lacking Microsomal Prostaglandin E Synthase-1
2004
Dynamically Crosslinked Gold Nanoparticle – Hyaluronan Hydrogels
2010
Prognostic and predictive markers in canine tumours: Rationale and relevance. A review
2005
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
2006
Caveolin: A possible biomarker of degradable metallic materials toxicity in vascular cells
2013
Expression of p16 Protein Identifies a Distinct Entity of Tonsillar Carcinomas Associated with Human Papillomavirus
2003
The first 30 years of p53: growing ever more complex
2009 Standout
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
2006 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Genotoxicity of the copper antineoplastic coordination complexes casiopeinas®
2011
The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer
2015
Age-Associated mRNA and miRNA Expression Changes in the Blood-Brain Barrier
2019 StandoutNobel
A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine
2005 Standout
Cutting Edge: The Spirochetemia of Murine Relapsing Fever Is Cleared by Complement-Independent Bactericidal Antibodies
2001
ROLE OF C5A IN INFLAMMATORY RESPONSES
2005
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Hydrogel bioelectronics
2018 Standout
Generation of a Complement-Independent Bactericidal IgM against a Relapsing Fever Borrelia
2004
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Biodegradable metals
2014 Standout
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003
B-Raf–dependent expression of vascular endothelial growth factor–A in Kaposi sarcoma–associated herpesvirus-infected human B cells
2005
Complement C5a Receptor Is Essential for the Optimal Generation of Antiviral CD8+ T Cell Responses
2004
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Synthesis, characterization and stability of a luteinizing hormone-releasing hormone (LHRH)-functionalized poly(amidoamine) dendrimer conjugate
2007
Advances in Copper Complexes as Anticancer Agents
2013 Standout
Prostaglandins and Inflammation
2011 Standout
When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system
2009
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network
2010
Standards and Infrastructure for Innovation Data Exchange
2012 StandoutScienceNobel
Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection
1995
DAMPs, PAMPs and alarmins: all we need to know about danger
2006 Standout
Robust Distal Tip Cell Pathfinding in the Face of Temperature Stress Is Ensured by Two Conserved microRNAS inCaenorhabditis elegans
2015 StandoutNobel
Works of Thilo Schlott being referenced
Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system
2004 Nobel
Analysis of adenomatous polyposis coli gene expression, APC locus-microsatellite instability and APC promoter methylation in the progression of melanocytic tumours
2004
POINT MUTATIONS AND NUCLEOTIDE INSERTIONS IN THE MDM2 ZINC FINGER STRUCTURE OF HUMAN TUMOURS
1997
Loss of Heterozygosity at 12q14-15 Often Occurs in Stage I Soft Tissue Sarcomas and Is Associated with MDM2 Amplification in Tumors at Various Stages
2003
Downregulation of the Retinoblastoma Gene Expression in the Progression of Malignant Melanoma
2001
Reverse Transcriptase Polymerase Chain Reaction for Detecting Ewing’s Sarcoma in Archival Fine Needle Aspiration Biopsies
1997
Specific Autologous Anti-Melanoma T Cell Response in vitro Using Monocyte-Derived Dendritic Cells
1998
Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation
2004
Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma
2005
p16 Alterations and retinoblastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract
2001
Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue
2005
Promoter hypermethylation of the 14-3-3 σ, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas
2006
GADD153 is an independent prognostic factor in melanoma: immunohistochemical and molecular genetic analysis.
2002
EXPRESSION OF GASTRIN RELEASING PEPTIDE RECEPTOR IN RENAL CELL CARCINOMAS: A POTENTIAL FUNCTION FOR THE REGULATION OF NEOANGIOGENESIS AND MICROVASCULAR PERFUSION
2005 Nobel
Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
2004
Human Tissue for In Vitro Research as an Alternative to Animal Experiments: A Charitable “Honest Broker” Model to Fulfil Ethical and Legal Regulations and to Protect Research Participants
2006
The In Situ Polymerase Chain Reaction for Detection of Chlamydia trachomatis
1998
Transitional cell carcinomas and nonurothelial carcinomas of the urinary bladder differ in the promoter methylation status of the caveolin-1, hDAB2IP and p53 genes, but not in the global methylation of Alu elements
2006
Role of reactive oxygen species in cisplatin-induced apoptosis of human malignant testicular germ cell lines
2004
Anaphylatoxin C5a Induces Monocyte Recruitment and Differentiation into Dendritic Cells by TNF-α and Prostaglandin E2-Dependent Mechanisms
2003
Bcl2 and Bax expression in naevi and melanomas and their relation to ploidy status and proliferation.
1999
Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
2004
The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies
1993